Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.
- DOI
- 10.1007/s40257-025-00997-x
- Published
- 2026 Jan
- Container
- American journal of clinical dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40257-025-00997-x,
title = {Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.},
author = {Rønnstad ATM and Isufi D and Bunick CG and Chovatiya R and Nielsen ML and Alinaghi F and Thomsen SF and Vestergaard C and Wollenberg A and Egeberg A and Thyssen JP and Loft N},
year = {2026},
journal = {American journal of clinical dermatology},
doi = {10.1007/s40257-025-00997-x},
url = {https://doi.org/10.1007/s40257-025-00997-x}
}RIS
TY - JOUR TI - Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis. AU - Rønnstad ATM AU - Isufi D AU - Bunick CG AU - Chovatiya R AU - Nielsen ML AU - Alinaghi F AU - Thomsen SF AU - Vestergaard C AU - Wollenberg A AU - Egeberg A AU - Thyssen JP AU - Loft N PY - 2026 JO - American journal of clinical dermatology DO - 10.1007/s40257-025-00997-x UR - https://doi.org/10.1007/s40257-025-00997-x ER -
APA
ATM, R., D, I., CG, B., R, C., ML, N., F, A., SF, T., C, V., A, W., A, E., JP, T., & N, L. (2026). Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.. American journal of clinical dermatology. https://doi.org/10.1007/s40257-025-00997-x
Source records
- pubmed · retrieved 2026-09-25T11:33:42.577Z